The Tri-Institutional Therapeutics Discovery Institute (TDI) is a collaborative initiative between Memorial Sloan Kettering Cancer Center, The Rockefeller University, and Weill Cornell Medicine in New York, NY. TDI aims to accelerate the translation of groundbreaking biological discoveries into preclinical studies by providing academic projects with industrial-scale technical support and unprecedented services in an academic environment.
Through strategic academic-industry partnerships and an Innovation Education Initiative, TDI empowers the Tri-I community to bridge the gap between bench and bedside, maximizing the impact of academic drug discoveries. Leveraging the resources, expertise, and support of its academic and industry partners, TDI plays a vital role in advancing drug discovery research and fostering innovation in the field.
Generated from the website